Salarius Pharmaceuticals Inc (SLRX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.84

About Salarius Pharmaceuticals Inc

Salarius Pharmaceuticals Inc. (SLRX) is a clinical-stage biotechnology company headquartered in Houston, Texas, specializing in the development of innovative epigenetic therapies targeting cancer. With a strong commitment to addressing unmet medical needs, Salarius aims to advance its promising pipeline of treatments that leverage the unique mechanisms of epigenetics to improve outcomes for patients battling various malignancies. The company is dedicated to advancing its research through rigo...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Salarius Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SLRX pay dividends?

Salarius Pharmaceuticals Inc (SLRX) does not currently pay a regular dividend.